Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Pharmacokinetic Modeling
44%
Pharmacodynamics
39%
Sepsis
39%
Replacement Therapy
30%
Ceftriaxone
28%
Cefepime
28%
Pharmacokinetic Parameter
23%
Therapeutic Drug Monitoring
21%
Pharmacokinetics
18%
Minimum Inhibitory Concentration
15%
Attention Deficit Disorder
14%
Inflammation
14%
Hydrocortisone
14%
Voriconazole
14%
Protein Binding
14%
Transcortin
14%
Flucloxacillin
14%
Pyrazinamide
14%
Carboxylesterase
14%
Model Selection
14%
Methylphenidate
14%
Dalbavancin
14%
Staphylococcal Infection
14%
Ruxolitinib
14%
Chronic Graft Versus Host Disease
14%
Meropenem
14%
Lormetazepam
14%
Volume of Distribution
9%
Antibiotics
8%
Elimination
8%
Biological Marker
7%
Drug Concentration
7%
C Reactive Protein
7%
Antibiotic Agent
6%
Keyphrases
Target Attainment
28%
High Dose
17%
Bayesian Methods
16%
Monte Carlo Simulation
16%
Sepsis
15%
Pharmacodynamics Target Attainment
15%
Critically Ill children
15%
Pharmacokinetic Parameters
14%
Attention Deficit Hyperactivity Disorder
14%
Ceftriaxone
14%
Restricted Sampling
14%
Population Pharmacokinetics
14%
Therapeutic Drug Monitoring
14%
Older Adults
14%
Genetic Variability
14%
Dalbavancin
14%
Methylphenidate
14%
Carboxylesterase 1 (CES1)
14%
Staphylococcal Infections
14%
Tuberculosis
14%
Pyrazinamide
14%
Pediatric Severe Sepsis
14%
Continuous Renal Replacement Therapy
14%
Continuous Infusion
14%
Cefepime
14%
Long-term Treatment
9%
Population Pharmacokinetic Model
9%
Minimum Inhibitory Concentration
8%
Tuberculosis Patients
7%
Pharmacokinetics
6%
Probability of Target Attainment
5%
Biochemistry, Genetics and Molecular Biology
Pharmacokinetics
36%
Drug Megadose
16%
Genetic Divergence
14%
Transcortin
14%
Binding Protein
14%
Carboxylesterase 1
14%
Mental Capacity
14%
Cortisol
8%
Blood Level
8%
Minimum Inhibitory Concentration
6%
Liquid
6%
